Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
ACTIVE_NOT_RECRUITING
Total Enrollment
30 participants
Study Classification
OBSERVATIONAL
Study Start Date
2023-01-09
Study Completion Date
2026-10-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Single center study to evaluate the feasibility of using 3 different strategies to measure adherence among children, adolescents, and young adults prescribed an anticoagulation medication
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Synchronization to Improve Non-Adherence to Cardiovascular Medications
NCT01963156
Chronic Disease
Cardiovascular Disease
Diabetes Mellitus
TERMINATED
NA
Medication Reconciliation in Comparison to an Extensive Medication Safety Check
NCT02413957
Elderly
Adverse Drug Event
COMPLETED
NA
Natural History Study of Azathioprine Adherence
NCT00143910
Kidney Transplant
COMPLETED
Effect of an Electronic Reminder System on Direct Oral Anticoagulant and Oral Diabetes Medication Adherence
NCT03753568
Anticoagulant Drugs
Diabetes Mellitus, Type 2
UNKNOWN
NA
Tools to Assess Medication Adherence
NCT04772066
Medication Adherence
UNKNOWN
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is an observational study with a maximum of 5 study visits during the 12-week study period. The study visit schedule has been designed to align with current clinical care practices. Adherence will be assessed via the EAMDs device, as well as by self-report measure in the BAT and by staff telephone inquiry regarding pharmacy refill data. Adherence data will be used to compute rates and trajectories of adherence to anticoagulants.
It is anticipated that this study will conclude in approximately 2 years, including data analysis.
It is anticipated that this study will conclude in approximately 2 years, including data analysis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Anticoagulation
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Observational Model Type
COHORT
Study Time Perspective
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Anticoagulated CCHMC patients ages 0 to 29.9 years and their caregivers (where applicable for patients \< 18 years)
* Able to provide informed consent
* Duration of anticoagulation planned for the outpatient setting is 4 weeks or longer
* Willing and able to participate in telephone and in person study visits
* For patients \< 18 years, both patient and caregiver agree to participate
* Able to provide informed consent
* Duration of anticoagulation planned for the outpatient setting is 4 weeks or longer
* Willing and able to participate in telephone and in person study visits
* For patients \< 18 years, both patient and caregiver agree to participate
Exclusion Criteria
* Unwilling or unable to provide informed consent
* Duration of anticoagulation is planned for \< 4 weeks in the outpatient setting
* Anticoagulant drug will not fit into the EAMD
* Unable to participate in telephone study visit
* Duration of anticoagulation is planned for \< 4 weeks in the outpatient setting
* Anticoagulant drug will not fit into the EAMD
* Unable to participate in telephone study visit
Maximum Eligible Age
29 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Hospital Medical Center, Cincinnati
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Responsibility Role
SPONSOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lori Luchtman-Jones, MD
Role: PRINCIPAL_INVESTIGATOR
Region V-East Great Lake Region, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
Site Status
Countries
Review the countries where the study has at least one active or historical site.
United States
References
Explore related publications, articles, or registry entries linked to this study.
Andrew M, David M, Adams M, Ali K, Anderson R, Barnard D, Bernstein M, Brisson L, Cairney B, DeSai D, et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood. 1994 Mar 1;83(5):1251-7.
Reference Type
BACKGROUND
Gibson BES, Chalmers EA et al. Thromboembolism in childhood: a prospective 2-year BPSU study in the United Kingdom. February 2001-February 2003. Br J Haematol. 2004;1:OC422
Reference Type
BACKGROUND
van Ommen CH, Heijboer H, Buller HR, Hirasing RA, Heijmans HS, Peters M. Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. J Pediatr. 2001 Nov;139(5):676-81. doi: 10.1067/mpd.2001.118192.
Reference Type
BACKGROUND
Raffini L, Huang YS, Witmer C, Feudtner C. Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007. Pediatrics. 2009 Oct;124(4):1001-8. doi: 10.1542/peds.2009-0768. Epub 2009 Sep 7.
Reference Type
BACKGROUND
Kerlin BA. Current and future management of pediatric venous thromboembolism. Am J Hematol. 2012 May;87 Suppl 1(0 1):S68-74. doi: 10.1002/ajh.23131. Epub 2012 Feb 24.
Reference Type
BACKGROUND
Monagle P, Newall F. Management of thrombosis in children and neonates: practical use of anticoagulants in children. Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):399-404. doi: 10.1182/asheducation-2018.1.399.
Reference Type
BACKGROUND
Monagle P, Chan AKC, Goldenberg NA, Ichord RN, Journeycake JM, Nowak-Gottl U, Vesely SK. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(2 Suppl):e737S-e801S. doi: 10.1378/chest.11-2308.
Reference Type
BACKGROUND
Luchtman-Jones L. Venous thromboembolism and anticoagulation safety: who is watching the children? Pediatr Blood Cancer. 2014 Nov;61(11):1916-7. doi: 10.1002/pbc.25145. Epub 2014 Jul 22. No abstract available.
Reference Type
BACKGROUND
Jones S, McLoughlin S, Piovesan D, Savoia H, Monagle P, Newall F. Safety and Efficacy Outcomes of Home and Hospital Warfarin Management Within a Pediatric Anticoagulation Clinic. J Pediatr Hematol Oncol. 2016 Apr;38(3):216-20. doi: 10.1097/MPH.0000000000000502.
Reference Type
BACKGROUND
Simons LE, Blount RL. Identifying barriers to medication adherence in adolescent transplant recipients. J Pediatr Psychol. 2007 Aug;32(7):831-44. doi: 10.1093/jpepsy/jsm030. Epub 2007 May 23.
Reference Type
BACKGROUND
Modi AC, Pai AL, Hommel KA, Hood KK, Cortina S, Hilliard ME, Guilfoyle SM, Gray WN, Drotar D. Pediatric self-management: a framework for research, practice, and policy. Pediatrics. 2012 Feb;129(2):e473-85. doi: 10.1542/peds.2011-1635. Epub 2012 Jan 4.
Reference Type
BACKGROUND
Rapoff M. Adherence to pediatric medical regimens. 2nd ed. Issues in Clinical Child Psychology. New York, NY: Springer Science+Business Media; 2010
Reference Type
BACKGROUND
Bhatia S, Landier W, Hageman L, Kim H, Chen Y, Crews KR, Evans WE, Bostrom B, Casillas J, Dickens DS, Maloney KW, Neglia JP, Ravindranath Y, Ritchey AK, Wong FL, Relling MV. 6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children's Oncology Group study. Blood. 2014 Oct 9;124(15):2345-53. doi: 10.1182/blood-2014-01-552166. Epub 2014 May 14.
Reference Type
BACKGROUND
Wu YP, Stenehjem DD, Linder LA, Yu B, Parsons BG, Mooney R, Fluchel MN. Adherence to Oral Medications During Maintenance Therapy Among Children and Adolescents With Acute Lymphoblastic Leukemia: A Medication Refill Analysis. J Pediatr Oncol Nurs. 2018 Mar/Apr;35(2):86-93. doi: 10.1177/1043454217741877. Epub 2017 Nov 30.
Reference Type
BACKGROUND
Quittner AL, Modi AC, Lemanek KL, Ievers-Landis CE, Rapoff MA. Evidence-based assessment of adherence to medical treatments in pediatric psychology. J Pediatr Psychol. 2008 Oct;33(9):916-36; discussion 937-8. doi: 10.1093/jpepsy/jsm064. Epub 2007 Sep 10.
Reference Type
BACKGROUND
Vrijens B, Antoniou S, Burnier M, de la Sierra A, Volpe M. Current Situation of Medication Adherence in Hypertension. Front Pharmacol. 2017 Mar 1;8:100. doi: 10.3389/fphar.2017.00100. eCollection 2017.
Reference Type
BACKGROUND
Riekert KA, Rand CS. Electronic monitoring of medication adherence: When is high-tech best? J Clin Psychol Med Settings. 2002;9:25-34
Reference Type
BACKGROUND
Chan AH, Harrison J, Black PN, Mitchell EA, Foster JM. Using electronic monitoring devices to measure inhaler adherence: a practical guide for clinicians. J Allergy Clin Immunol Pract. 2015 May-Jun;3(3):335-49.e1-5. doi: 10.1016/j.jaip.2015.01.024. Epub 2015 Apr 1.
Reference Type
BACKGROUND
McGrady ME, Holbein CE, Smith AW, Morrison CF, Hommel KA, Modi AC, Pai ALH, Ramsey RR. An Independent Evaluation of the Accuracy and Usability of Electronic Adherence Monitoring Devices. Ann Intern Med. 2018 Sep 18;169(6):419-422. doi: 10.7326/M17-3306. Epub 2018 May 22. No abstract available.
Reference Type
BACKGROUND
McGrady ME, Ramsey RR. Using Electronic Monitoring Devices to Assess Medication Adherence: a Research Methods Framework. J Gen Intern Med. 2020 Sep;35(9):2707-2714. doi: 10.1007/s11606-020-05905-z. Epub 2020 May 21.
Reference Type
BACKGROUND
Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, Agoritsas T, Mistry N, Iorio A, Jack S, Sivaramalingam B, Iserman E, Mustafa RA, Jedraszewski D, Cotoi C, Haynes RB. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014 Nov 20;2014(11):CD000011. doi: 10.1002/14651858.CD000011.pub4.
Reference Type
BACKGROUND
De Bleser L, De Geest S, Vandenbroeck S, Vanhaecke J, Dobbels F. How accurate are electronic monitoring devices? A laboratory study testing two devices to measure medication adherence. Sensors (Basel). 2010;10(3):1652-60. doi: 10.3390/s100301652. Epub 2010 Mar 2.
Reference Type
BACKGROUND
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H30MC24047
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
Anticoagulation Adherence
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Pilot Study to Improve Medication Management in Older Adults
NCT04709640
COMPLETED
NA
Medicines Reconciliation at an Intensive Care Unit
NCT03173690
UNKNOWN
NA
Adolescent Knowledge of Their Medications
NCT00717327
COMPLETED
General Practitioner (GP) Practice Based Pharmacist Input to Medicines Optimisation
NCT03241498
COMPLETED
NA
Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use
NCT05351749
ACTIVE_NOT_RECRUITING
NA
Tailored Intervention to Improve Medication Adherence in Patients With Hypertension
NCT01742923
COMPLETED
NA
Effectiveness of Pre-Consultation Medication Reconciliation Service in Reducing Unintentional Medication Discrepancies During Transition of Care From Hospital Discharge to Primary Care Setting
NCT03181906
COMPLETED
NA
A Trial for a Personalized Medication Management Platform to Improve Medication Adherence
NCT02197689
COMPLETED
NA
Medication Adherence Clinical Decision Support
NCT03748420
COMPLETED
NA
Comprehensive Management of Drug Prescriptions Throughout the Elderly Person's Hospital Care
NCT03666793
COMPLETED
NA
De-Implementation of Inappropriate Antimicrobial Use After Cardiac Device Procedures
NCT05020418
ENROLLING_BY_INVITATION
NA
ABM for ACO Beneficiaries
NCT02137551
COMPLETED
NA
Novel Approaches for Quantitative Assessment of Adherence
NCT04535934
COMPLETED
Medication Reconciliation for Patients Over 65 Years Old : Cost Analysis of the Process Implemented in the Polyvalent Internal Medical Unit of Rennes University Hospital
NCT03670433
COMPLETED
Effect of Community Pharmacist Intervention on Adherence to Long-Term Medications
NCT02604901
COMPLETED
NA
Co-Development and Evaluation of a Complex Intervention to Increase Medication Safety in Nursing Homes
NCT04990986
COMPLETED
NA
OptiMEDs Pilot Study
NCT04142645
COMPLETED
NA
Optimizing Antibiotics Prescription
NCT06436690
ACTIVE_NOT_RECRUITING
NA
Nurse-led Intervention to Improve Phosphate Binder Adherence
NCT02063490
COMPLETED
NA
Benefit of a Collaborative Approach to Improve the Quality of Medicines Use in Elderly Inpatients
NCT00279656
COMPLETED
PHASE4
Multi-Center Medication Reconciliation Quality Improvement Study
NCT01337063
COMPLETED
NA
Medication Use and Quality of Life Among Older People
NCT05123313
ACTIVE_NOT_RECRUITING
NA
The Medication Metronome Project - Study to Facilitate Follow-up Testing Resulting From Prescribed Medications to Improve Patient Safety and Care
NCT01586897
COMPLETED
NA
Effect of an Opioid Disposal Pouch Versus Usual Care on Post Discharge Disposal of Unused Medication
NCT04553588
COMPLETED
NA
MEdication Counselling Models for Outpatient oRal antIcoaguLation
NCT06290440
NOT_YET_RECRUITING
NA